Equillium, Inc. Soared

Tue, Dec 29, 2020 at 05:30 PM
Equillium, Inc. Soared

Equillium, Inc. (EQ:NASDAQ) jumped higher at $6.18, representing a gain of 41.7%. On Mon 28 Dec 20, EQ:NASDAQ touched a New 2-Week Low of $4.36. The stock got featured on our News Catalysts scanner on Thu 10 Dec 20 at 08:08 PM in the 'EARNINGS' category. From Mon 14 Dec 20, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Fri 30 Oct 20 at $7.51 with a volume of 17M+, and its share price has been moving sideways in recent weeks.

About Equillium, Inc. (EQ:NASDAQ)

Equillium Inc is a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, which is a clinical stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus and multiple sclerosis.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.